menu
    • menu

    Company profile for Hypera Pharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Hypera Pharma is the largest pharmaceutical company in Brazil and is present in all relevant segments of the sector. With a leading position in several categories, it offers high quality and safe products, continuously investing in innovation and growing in a sustainable way, so that people live more and better. Hypera Pharma is organized into three large business units, leaders in the markets in which they are present:

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hypera PharmaBrazil Flag
    Country
    Country
    Brazil
    Address
    Address
    AV. MAGALHÃES DE CASTRO, 4800 - 24º ANDAR - EDIFÍCIO CONTINENTAL TOWER - BA...
    Telephone
    Telephone
    (11) 3147-7900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hypera.com.br
    Linkedin
    Linkedin
    https://www.linkedin.com/company/hypermarcas-s-a/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Brazil's Hypera to launch an Ozempic generic in 2026
    Brazil's Hypera to launch an Ozempic generic in 2026

    22 Mar 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/brazils-hypera-launch-an-ozempic-generic-2026-ceo-says-2025-03-21/

    REUTERS
    22 Mar 2025
    Share Share
    Another OTC product sale for Sanofi, this one to Hypera Pharma
    Another OTC product sale for Sanofi, this one to Hypera Pharma

    15 Jul 2021

    // Kevin Dunleavy FIERCEPHARMA

    https://www.fiercepharma.com/pharma/deal-hypera-brazil-sanofi-continues-to-tighten-belt-and-transform-consumer-healthcare-unit

    Kevin Dunleavy FIERCEPHARMA
    15 Jul 2021
    Share Share
    Takeda sells select products portfolio to Hypera Pharma
    Takeda sells select products portfolio to Hypera Pharma

    01 Feb 2021

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/takeda-hypera-pharma/

    PHARMACEUTICAL-TECHNOLOGY
    01 Feb 2021
    Share Share
    Takeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma
    Takeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma

    29 Jan 2021

    // BUSINESSWIRE

    https://www.businesswireindia.com/takeda-completes-sale-of-select-otc-and-non-core-assets-to-hypera-pharma-71313.html#:~:text=Pharmaceutical%20Company%20Limited-,Takeda%20Completes%20Sale%20of%20Select%20OTC%20and,Core%20Assets%20to%20Hypera%20Pharma&text=Osaka%2C%20Japan%3A&text=(%E2%80%9CHypera%20Pharma%E2%80%9D)%20for,first%20announced%20in%20March%202020.

    BUSINESSWIRE
    29 Jan 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search